Antibiotic Treatment Against Methicillin-Resistant Staphylococcus aureus Hospital- and Ventilator-acquired Pneumonia: A Step Forward but the Battle Continues | Zendy

Antoni Torres | Zendy

Open Access

Antibiotic Treatment Against Methicillin-Resistant Staphylococcus aureus Hospital- and Ventilator-acquired Pneumonia: A Step Forward but the Battle Continues

Author(s) -

Antoni Torres

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir907

Subject(s) - medicine , staphylococcus aureus , antibiotics , pneumonia , methicillin resistant staphylococcus aureus , ventilator associated pneumonia , battle , intensive care medicine , staphylococcal infections , microbiology and biotechnology , bacteria , history , genetics , archaeology , biology

to 70%. In the last 10 years, the pharmaceutical industry has made efforts to develop antibiotics against gram-positive cocci, including MRSA. Linezolid, a member of the oxazolidinone family, is an antibiotic that has been used for more than 10 years to combat staphylococcal infections. In randomized clinical trials (RCTs),

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research